Japan 3D-Printing Medical Device Market (2026-2035): Market Size and Analysis Report Released

Japan's 3D-printing medical device market was valued at approximately US$187.19 million in 2025 and is forecast to expand at a compound annual growth rate of 16.9% from 2026 to 2035, reaching approximately US$892.13 million by 2035. Dental is expected to account for approximately 35% of the market, making it one of the largest categories overall. SLS is regarded as a leading technology, while other methods, including EBM, are considered important depending on the application.

Growth drivers include demand for patient-specific implants, adoption of additive manufacturing, population aging and the rising prevalence of chronic diseases, wider use of minimally invasive treatments, advances in materials technology, and collaboration between healthcare institutions and technology companies. The report also notes that the number of patients with rheumatoid arthritis could increase potential demand, while pointing to the effects of patient-specific factors related to lesion location and surgical indications.

Technology trends include real-time quality monitoring, with the collaboration between PHC and Cyfuse Biomedical cited as an example. As of 2025, Ricoh's technology for manufacturing full-color resin components and efforts to strengthen digital workflows for 3D printing are attracting attention. Competition extends beyond the ability to simply produce items using 3D printing, with the overall balance of strength, biocompatibility, color reproduction, surface quality, dimensional accuracy, and production speed becoming critical.

Hospitals play the primary role among end users, while research institutions, specialized clinics, and pharmaceutical and biotechnology companies are also considered important market segments. By region, Western Japan is expected to lead the market, although this report does not provide detailed figures for its specific market share or CAGR.